Saltar al contenido
Merck

Heterozygosity of Chaperone Grp78 Reduces Intestinal Stem Cell Regeneration Potential and Protects against Adenoma Formation.

Cancer research (2018-09-21)
Jooske F van Lidth de Jeude, Claudia N Spaan, Bartolomeus J Meijer, Wouter L Smit, Tanya T D Soeratram, Mattheus C B Wielenga, B Florien Westendorp, Amy S Lee, Sander Meisner, Jacqueline L M Vermeulen, Manon E Wildenberg, Gijs R van den Brink, Vanesa Muncan, Jarom Heijmans
RESUMEN

Deletion of endoplasmic reticulum resident chaperone Grp78 results in activation of the unfolded protein response and causes rapid depletion of the entire intestinal epithelium. Whether modest reduction of Grp78 may affect stem cell fate without compromising intestinal integrity remains unknown. Here, we employ a model of epithelial-specific, heterozygous Grp78 deletion by use of VillinCreERT2-Rosa26ZsGreen/LacZ-Grp78+/fl mice and organoids. We examine models of irradiation and tumorigenesis, both in vitro and in vivo Although we observed no phenotypic changes in Grp78 heterozygous mice, Grp78 heterozygous organoid growth was markedly reduced. Irradiation of Grp78 heterozygous mice resulted in less frequent regeneration of crypts compared with nonrecombined (wild-type) mice, exposing reduced capacity for self-renewal upon genotoxic insult. We crossed mice to Apc-mutant animals for adenoma studies and found that adenomagenesis in Apc heterozygous-Grp78 heterozygous mice was reduced compared with Apc heterozygous controls (1.43 vs. 3.33; P < 0.01). In conclusion, epithelium-specific Grp78 heterozygosity compromises epithelial fitness under conditions requiring expansive growth such as adenomagenesis or regeneration after γ-irradiation. These results suggest that Grp78 may be a therapeutic target in prevention of intestinal neoplasms without affecting normal tissue.Significance: Heterozygous disruption of chaperone protein Grp78 reduces tissue regeneration and expansive growth and protects from tumor formation without affecting intestinal homeostasis. Cancer Res; 78(21); 6098-106. ©2018 AACR.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Reactivo TRI®, For processing tissues, cells cultured in monolayer or cell pellets
Sigma-Aldrich
4-hidroxitamoxifeno, ≥70% Z isomer (remainder primarily E-isomer)
Sigma-Aldrich
3,3′-Diaminobencidina tetrahydrochloride hydrate, ≥96%